| E-PP-1354 |
Hylambatin |
100mg |
Detail
|
Inquire |
| E-PP-1355 |
Hypercalcemia Malignancy Factor (1-34), amide, human |
10mg |
Detail
|
Inquire |
| E-PP-1356 |
Hypercalcemia Malignancy Factor (1-34), human |
10mg |
Detail
|
Inquire |
| E-PP-1357 |
Hypercalcemia Malignancy Factor (1-40) |
10mg |
Detail
|
Inquire |
| E-PP-1358 |
Hypercalcemia Malignancy Factor (7-34), amide, human |
10mg |
Detail
|
Inquire |
| E-PP-1359 |
Hypertrehalosaemic Neuropeptide, Heliothis zea |
100mg |
Detail
|
Inquire |
| E-PP-1360 |
Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea |
100mg |
Detail
|
Inquire |
| E-PP-1361 |
Hypocretin (70-98), human |
10mg |
Detail
|
Inquire |
| E-PP-1362 |
I-309, human |
10mg |
Detail
|
Inquire |
| E-PP-1363 |
IELLQAR (8-branch MAPS) Selectin Binding Peptide |
100mg |
Detail
|
Inquire |
| E-PP-1364 |
IGF-I (1-3) |
100mg |
Detail
|
Inquire |
| E-PP-1365 |
IGF-I (24-41) |
10mg |
Detail
|
Inquire |
| E-PP-1366 |
IGF-I (30-41) |
100mg |
Detail
|
Inquire |
| E-PP-1367 |
IGF-I Analog |
100mg |
Detail
|
Inquire |
| E-PP-1368 |
IGF-II (33-40) |
100mg |
Detail
|
Inquire |
| E-PP-1369 |
IL-1 Receptor Peptide, human |
100mg |
Detail
|
Inquire |
| E-PP-1370 |
IL-1a (223-250), human |
10mg |
Detail
|
Inquire |
| E-PP-1371 |
IL-1b (178-207), human |
10mg |
Detail
|
Inquire |
| E-PP-1372 |
IL-1b (208-240), human |
10mg |
Detail
|
Inquire |
| E-PP-1373 |
IL-6 (88-121), human |
10mg |
Detail
|
Inquire |
| E-PP-1374 |
IL-8 (-5 to +5) |
100mg |
Detail
|
Inquire |
| E-PP-1375 |
IL-8 Inhibitor |
100mg |
Detail
|
Inquire |
| E-PP-1376 |
IL-8ra (9-29) |
10mg |
Detail
|
Inquire |
| E-PP-1377 |
Indolicidin |
100mg |
Detail
|
Inquire |
| E-PP-1378 |
Influenza A M2 coat protein (22-46) |
10mg |
Detail
|
Inquire |
| E-PP-1379 |
Influenza A NP (366-374) |
100mg |
Detail
|
Inquire |
| E-PP-1380 |
Influenza A NP (366-374)Strain A/NT/60/68 |
100mg |
Detail
|
Inquire |
| E-PP-1381 |
Influenza A NP (366-374)Strain A/PR/8/35 |
100mg |
Detail
|
Inquire |
| E-PP-1382 |
Influenza HA (110-119) |
100mg |
Detail
|
Inquire |
| E-PP-1383 |
Influenza HA (110-120) |
100mg |
Detail
|
Inquire |
| E-PP-1384 |
Influenza HA (204-212) |
100mg |
Detail
|
Inquire |
| E-PP-1385 |
Influenza HA (210-219) |
100mg |
Detail
|
Inquire |
| E-PP-1386 |
Influenza HA (307-319) |
100mg |
Detail
|
Inquire |
| E-PP-1387 |
Influenza HA (518-526) |
100mg |
Detail
|
Inquire |
| E-PP-1388 |
Influenza HA (529-537) |
100mg |
Detail
|
Inquire |
| E-PP-1389 |
Influenza NP (50-57) |
100mg |
Detail
|
Inquire |
| E-PP-1390 |
Influenza NP (147-155) |
100mg |
Detail
|
Inquire |
| E-PP-1391 |
Influenza NP (482-489) |
100mg |
Detail
|
Inquire |
| E-PP-1392 |
Insulin B (9-23) |
10mg |
Detail
|
Inquire |
| E-PP-1393 |
Insulin Receptor (1142-1153) |
100mg |
Detail
|
Inquire |
| E-PP-1394 |
Insulin Receptor (1142-1153), amide |
100mg |
Detail
|
Inquire |
| E-PP-1395 |
Insulin Receptor (1142-1153), pTyr1150, Biotinylated |
10mg |
Detail
|
Inquire |
| E-PP-1396 |
Insulin-like Growth Factor I (57-70) |
100mg |
Detail
|
Inquire |
| E-PP-1397 |
Insulin-Like Growth Factor II (69-84) |
10mg |
Detail
|
Inquire |
| E-PP-1398 |
Interleukin II (60-70) |
100mg |
Detail
|
Inquire |
| E-PP-1399 |
Interleukin-1β Convertase Substrate |
100mg |
Detail
|
Inquire |
| E-PP-1400 |
Interleukin-6 Receptor, partial |
100mg |
Detail
|
Inquire |
| E-PP-1401 |
Intermedin, human |
10mg |
Detail
|
Inquire |
| E-PP-1402 |
Intermedin, rat |
10mg |
Detail
|
Inquire |
| E-PP-1403 |
Intermedin-53, human |
10mg |
Detail
|
Inquire |
